Deslorelin Acetate — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog (male)	SC (subcutaneous implant)	4.7 mg or 9.4 mg implant (depending on product)	Single implant; effect lasts 6-12 months	Duration: 6-12 months Notes: Implant placed subcutaneously between the shoulder blades. For BPH, effect may be seen within 2-4 weeks. For contraception, ensure implant is placed before onset of breeding season.
Cat (male)	SC (subcutaneous implant)	4.7 mg implant	Single implant; effect lasts 6-12 months	Duration: 6-12 months Notes: Implant placed subcutaneously in the scruff of the neck. May cause temporary flare effect with increased testosterone for a few days.
Horse (mare)	IM (intramuscular injection)	1.5 mg (as a solution)	Single injection to induce ovulation	Duration: Ovulation occurs within 24-48 hours Notes: Used to induce ovulation in cycling mares. Administer when a dominant follicle is present (≥35 mm). Not for long-term contraception.
Rabbit (male)	SC (subcutaneous implant)	4.7 mg implant	Single implant; effect lasts 6-12 months	Duration: 6-12 months Notes: Implant placed subcutaneously. May be used for contraception or behavior modification.
Exotic mammals (e.g., ferret)	SC (subcutaneous implant)	4.7 mg or 9.4 mg implant (based on size)	Single implant; effect lasts 6-12 months	Duration: 6-12 months Notes: Dose based on body weight and species. Consult a veterinary specialist for exotic animals.

Clinical Indications & Species Uses

General Indications

Temporary contraception in male and female animals
Management of hormone-dependent conditions (e.g., BPH, certain tumors)
Suppression of reproductive behaviors (e.g., aggression, mounting, urine marking)

Dog (Canine)

Temporary contraception in male dogs (chemical castration)
Management of benign prostatic hyperplasia (BPH)
Treatment of testosterone-dependent tumors (e.g., perianal adenoma)
Suppression of aggressive behavior associated with testosterone

Cat (Feline)

Temporary contraception in male cats (chemical castration)
Suppression of urine spraying and territorial aggression in male cats
Management of feline hypersexuality

Horse (Equine)

Induction of ovulation in mares (to time breeding)
Treatment of persistent estrus behavior in mares (when used as a contraceptive)

Cattle (Bovine)

Potential for contraception in non-food animals (e.g., zoo animals)

Small Ruminants (Sheep / Goat)

Potential for contraception in non-food animals

Rabbit & Small Mammals

Temporary contraception in male rabbits
Management of aggressive behavior in male rabbits

Avian & Poultry

Potential for contraception in pet birds (e.g., parrots) to manage reproductive behavior

Exotic & Other Species

Contraception in various exotic mammals (e.g., ferrets, rodents, primates)
Management of reproductive-related behaviors in zoo animals

Pharmacology & Mechanism of Action

Drug Class: GnRH analog (gonadotropin-releasing hormone agonist) | Pharmacological Group: Reproductive hormone

Mechanism of Action: Deslorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH). It binds with high affinity to GnRH receptors on pituitary gonadotroph cells. Initially, it stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a transient increase in sex steroid production. However, with continuous exposure, it causes downregulation and desensitization of GnRH receptors, resulting in suppression of LH and FSH secretion. This leads to a decrease in gonadal steroid production (testosterone in males, estradiol and progesterone in females), effectively inducing a reversible chemical castration or contraception. The initial stimulatory phase may cause a temporary flare effect.

Pharmacodynamics: Deslorelin exerts its effects by modulating the hypothalamic-pituitary-gonadal axis. After administration, there is an initial surge of LH and FSH (flare effect) lasting a few days, followed by a prolonged suppression of gonadotropins. In males, testosterone levels decrease to castrate levels within 1-2 weeks and remain suppressed for the duration of the implant's effectiveness (typically 6-12 months). In females, it suppresses estrus and ovulation, preventing pregnancy. The duration of action depends on the dose and species. In horses, it is used to induce ovulation in mares by mimicking the natural GnRH surge, but in other species, it is primarily used for contraception or suppression of reproductive behavior.

⚡ Pharmacokinetics Summary

Absorption: Deslorelin is administered as a subcutaneous implant or injectable solution. The implant provides slow, sustained release over months. Absorption from the implant site is gradual, maintaining therapeutic levels. Injectable solutions are absorbed rapidly, but are less commonly used for long-term effects.

Distribution: Deslorelin is a small peptide that distributes widely in body tissues. It crosses the blood-brain barrier to some extent, but its primary site of action is the pituitary gland. It is not significantly bound to plasma proteins.

Metabolism: Deslorelin is rapidly metabolized by peptidases in the liver and kidneys. The metabolic pathway involves cleavage of peptide bonds, resulting in inactive fragments.

Excretion: Metabolites are excreted primarily in the urine, with a small amount in feces. The elimination half-life is short (minutes) for the parent compound, but the implant provides a sustained release over months.

Half-Life: Short (minutes) for the parent drug; implant provides prolonged effect for 6-12 months depending on species and dose.

Bioavailability: High for subcutaneous implant (near 100% due to sustained release). Injectable solution has high bioavailability but rapid clearance.

Protein Binding: Low (approximately 15-20%)

Available Formulations & Strengths

Subcutaneous implant (slow-release) 4.7 mg, 9.4 mg (SC)

Injectable solution 1.5 mg/mL (for equine use) (IM)

Contraindications & Clinical Warnings

Contraindications:

Hypersensitivity to deslorelin or any component of the formulation
Pregnancy or suspected pregnancy (unless intended for abortion, but not recommended)
Use in animals intended for breeding (unless temporary contraception is desired)
Use in food-producing animals (due to lack of withdrawal times and regulatory approval)

Warnings & Clinical Precautions:

Transient flare effect: initial increase in testosterone/estrogen may cause temporary worsening of clinical signs (e.g., aggression, prostatic enlargement) for 1-2 weeks.
Not for use in animals with undescended testicles (cryptorchid) unless surgical removal is planned.
Use with caution in animals with hepatic or renal impairment (no specific studies).
In mares, only use to induce ovulation when a mature follicle is present; otherwise, may not be effective.
Implant may migrate; ensure proper placement.
In male dogs, may cause temporary infertility; if breeding is desired, wait until implant effect wears off.
In cats, may cause temporary weight gain and lethargy.
In horses, may cause local injection site reactions.
Keep out of reach of children; avoid accidental self-injection (may cause hormonal effects).

Adverse Effects & Reactions

Common:

Local swelling or reaction at implant site
Temporary increase in testosterone/estrogen (flare effect) leading to increased aggression or mounting behavior for a few days
Lethargy or mild depression
Decreased libido (after flare effect)
Weight gain (in cats)

Serious / Severe:

Anaphylaxis (rare)
Prolonged suppression of fertility (if implant is not removed, but reversible after removal)
In mares, failure to ovulate if used incorrectly
Tumor progression if used for hormone-dependent tumors without surgical removal

Rare:

Injection site abscess
Implant migration
Behavioral changes (e.g., increased anxiety)
Alopecia at implant site

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Progestins (e.g., medroxyprogesterone)	May have additive suppressive effects on the reproductive axis; not commonly used together.	Moderate
Androgens (e.g., testosterone)	May counteract the effects of deslorelin; avoid concurrent use.	High
GnRH antagonists (e.g., cetrorelix)	May block the effects of deslorelin; not commonly used in veterinary medicine.	Moderate
Corticosteroids	May alter the immune response; no significant interaction reported, but monitor.	Mild

Overdose & Toxicity Management

Signs of Toxicity:

Prolonged suppression of reproductive function
Excessive flare effect (e.g., severe aggression, prostatic enlargement)
Local tissue reaction at implant site
In mares, multiple ovulations or ovarian hyperstimulation (rare)

Emergency Treatment Protocol: There is no specific antidote. Treatment is symptomatic and supportive. If an overdose is suspected, remove the implant if possible. Monitor reproductive hormone levels and provide supportive care. In cases of severe flare effect, consider short-term use of anti-androgens or sedatives. Most effects are reversible upon implant removal.

Food Animal Withdrawal Times

Deslorelin is not approved for use in food-producing animals. Therefore, no withdrawal times are established. Use in food animals is prohibited in many countries. For non-food animals, no withdrawal times are required.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F).

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from light. Do not freeze. Keep in original packaging until use.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: FDA-approved for use in dogs (Suprelorin) and horses (Ovuplant). Not approved for cats, but commonly used extra-label.

Extra-Label (Off-Label) Use: In the US, deslorelin is approved for use in dogs (Suprelorin) and horses (Ovuplant). Extra-label use in other species is permitted under AMDUCA (Animal Medicinal Drug Use Clarification Act) for non-food animals, provided a valid veterinarian-client-patient relationship exists. Use in food animals is prohibited due to lack of withdrawal times and safety data.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Deslorelin is a valuable tool for temporary contraception and management of hormone-dependent conditions in companion animals. The subcutaneous implant provides long-lasting effects with minimal owner compliance issues. The initial flare effect should be explained to owners to avoid concerns. In male dogs, it is particularly useful for BPH and testosterone-related aggression. In cats, it can reduce urine spraying. In mares, it is used to induce ovulation for timed breeding. Always ensure proper placement of the implant and monitor for adverse effects. For food animals, do not use due to regulatory restrictions. For exotic animals, consult a specialist for dosing and monitoring.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)